China · Delayed Price · Currency is CNY Mingchen Health Statistics
Total Valuation
Mingchen Health has a market cap or net worth of CNY 6.42 billion. The enterprise value is 6.18 billion.
| Market Cap | 6.42B |
| Enterprise Value | 6.18B |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mingchen Health has 264.93 million shares outstanding. The number of shares has decreased by -0.26% in one year.
| Current Share Class | 264.93M |
| Shares Outstanding | 264.93M |
| Shares Change (YoY) | -0.26% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 41.84% |
| Owned by Institutions (%) | 4.68% |
| Float | 154.08M |
Valuation Ratios
The trailing PE ratio is 260.80.
| PE Ratio | 260.80 |
| Forward PE | n/a |
| PS Ratio | 4.09 |
| PB Ratio | 7.88 |
| P/TBV Ratio | 14.03 |
| P/FCF Ratio | 96.56 |
| P/OCF Ratio | 41.55 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 249.46 |
| EV / Sales | 3.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 92.94 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.73 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 7.95 |
| Debt / FCF | 1.64 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.82% and return on invested capital (ROIC) is 0.50%.
| Return on Equity (ROE) | 2.82% |
| Return on Assets (ROA) | 0.28% |
| Return on Invested Capital (ROIC) | 0.50% |
| Return on Capital Employed (ROCE) | 0.62% |
| Weighted Average Cost of Capital (WACC) | 7.46% |
| Revenue Per Employee | 1.24M |
| Profits Per Employee | 19,548 |
| Employee Count | 1,267 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 9.16 |
Taxes
In the past 12 months, Mingchen Health has paid 19.99 million in taxes.
| Income Tax | 19.99M |
| Effective Tax Rate | 46.17% |
Stock Price Statistics
The stock price has increased by +60.78% in the last 52 weeks. The beta is 0.61, so Mingchen Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +60.78% |
| 50-Day Moving Average | 22.12 |
| 200-Day Moving Average | 20.07 |
| Relative Strength Index (RSI) | 69.59 |
| Average Volume (20 Days) | 5,412,850 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mingchen Health had revenue of CNY 1.57 billion and earned 24.77 million in profits. Earnings per share was 0.09.
| Revenue | 1.57B |
| Gross Profit | 864.36M |
| Operating Income | 5.32M |
| Pretax Income | 43.30M |
| Net Income | 24.77M |
| EBITDA | 11.57M |
| EBIT | 5.32M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 348.60 million in cash and 109.12 million in debt, with a net cash position of 239.48 million or 0.90 per share.
| Cash & Cash Equivalents | 348.60M |
| Total Debt | 109.12M |
| Net Cash | 239.48M |
| Net Cash Per Share | 0.90 |
| Equity (Book Value) | 815.09M |
| Book Value Per Share | 3.06 |
| Working Capital | 307.29M |
Cash Flow
In the last 12 months, operating cash flow was 154.50 million and capital expenditures -88.02 million, giving a free cash flow of 66.48 million.
| Operating Cash Flow | 154.50M |
| Capital Expenditures | -88.02M |
| Depreciation & Amortization | 6.25M |
| Net Borrowing | 80.00M |
| Free Cash Flow | 66.48M |
| FCF Per Share | 0.25 |
Margins
Gross margin is 55.04%, with operating and profit margins of 0.34% and 1.58%.
| Gross Margin | 55.04% |
| Operating Margin | 0.34% |
| Pretax Margin | 2.76% |
| Profit Margin | 1.58% |
| EBITDA Margin | 0.74% |
| EBIT Margin | 0.34% |
| FCF Margin | 4.23% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.21%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.21% |
| Dividend Growth (YoY) | -66.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 58.08% |
| Buyback Yield | 0.26% |
| Shareholder Yield | 0.47% |
| Earnings Yield | 0.39% |
| FCF Yield | 1.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 31, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | May 31, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |